Company Filing History:
Years Active: 1990-1998
Title: Susan W Schwendner: Innovator in Radioiodinated Phospholipid Ether Analogues
Introduction
Susan W Schwendner is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of biomedical research, particularly in the development of novel radioiodinated phospholipid ether analogues. With a total of 5 patents to her name, her work has the potential to impact cancer treatment and diagnostics.
Latest Patents
Among her latest patents, Schwendner has developed radioiodinated phospholipid ether analogues that are tumor-specific. These analogues feature a triglycerol backbone structure, which is substituted at the 3-position with an alkyl phosphocholine. Additionally, they include a monoiodinated benzoyl side chain substituted at the 2-position, adhering to a specific general formula. This innovative approach aims to enhance the specificity and effectiveness of cancer therapies.
Career Highlights
Susan W Schwendner is affiliated with the University of Michigan, where she continues her research and development efforts. Her work has garnered attention for its potential applications in targeted cancer therapies, showcasing her commitment to advancing medical science.
Collaborations
Throughout her career, Schwendner has collaborated with notable colleagues, including Raymond E Counsell and Karen L Meyer. These partnerships have contributed to the success and impact of her research initiatives.
Conclusion
Susan W Schwendner stands out as a key figure in the field of biomedical innovation, particularly with her advancements in radioiodinated phospholipid ether analogues. Her contributions are paving the way for future developments in cancer treatment.